Home
Archive
Subscribe
The Renewal
Logo

ReHeart


Twenty years. Seven patients. A conditional approval.

Twenty years. Seven patients. A conditional approval.

In March, Japan approved the world's first iPSC-derived therapies. Here is what the evidence behind that approval actually looks like.

May 7, 2026

•

6 min read

background

The Renewal

Real regenerative medicine news, explained honestly, in ten minutes a week.

NAVIGATE

STAY INFORMED

Join readers who want the truth about regenerative medicine.

© 2026 The Renewal.
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv